BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24455220)

  • 21. Evaluation of the Impact of Mandating Health Care Providers to Offer Hepatitis C Virus Screening to All Persons Born During 1945-1965 - New York, 2014.
    Flanigan CA; Leung SJ; Rowe KA; Levey WK; King A; Sommer JN; Morne JE; Zucker HA
    MMWR Morb Mortal Wkly Rep; 2017 Sep; 66(38):1023-1026. PubMed ID: 28957037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving access to care for people who inject drugs: Qualitative evaluation of project ITTREAT-An integrated community hepatitis C service.
    Phillips C; Schulkind J; O'Sullivan M; Edelman N; Smith HE; Verma S; Jones CJ
    J Viral Hepat; 2020 Feb; 27(2):176-187. PubMed ID: 31566851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of point-of-care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: An Australian pilot study.
    Howell J; Traeger MW; Williams B; Layton C; Doyle JS; Latham N; Draper B; Bramwell F; Membrey D; McPherson M; Roney J; Stoové M; Thompson AJ; Hellard ME; Pedrana A
    J Viral Hepat; 2022 May; 29(5):375-384. PubMed ID: 35274403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Point-of-care testing for hepatitis C virus infection at alternative and high-risk sites: an Italian pilot study in a dental clinic.
    Parisi MR; Tecco S; Gastaldi G; Polizzi E; D'Amicantonio T; Negri S; Gardini I; Schlusnus K; Gherlone E; Capparè P; Lazzarin A
    New Microbiol; 2017 Oct; 40(4):242-245. PubMed ID: 28825443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The costs and impacts of testing for hepatitis C virus antibody in public STD clinics.
    Honeycutt AA; Harris JL; Khavjou O; Buffington J; Jones TS; Rein DB
    Public Health Rep; 2007; 122 Suppl 2(Suppl 2):55-62. PubMed ID: 17542455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The feasibility and acceptability of integrating hepatitis C and HIV diagnostic testing on centralized molecular laboratory platforms in Myanmar.
    Naing TS; Yee WW; Aung HT; Oo KY; Tint KS; Boeke CE; Chan Y; Witschi M; Nwe N; Markby J; Shilton S; Aung KS; Oo HN; Aye MM; Htay TT
    PLoS One; 2023; 18(5):e0282585. PubMed ID: 37195968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early Identification and Linkage to Care for People with Chronic HBV and HCV Infection: The HepTLC Initiative.
    Ramirez G; Cabral R; Patterson M; Schoenbachler BT; Bedell D; Smith BD; Vellozzi C; Beckett GA
    Public Health Rep; 2016; 131 Suppl 2(Suppl 2):5-11. PubMed ID: 27168655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Point-of-care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination.
    Forns X; Colom J; García-Retortillo M; Quer JC; Lens S; Martró E; Domínguez-Hernández R; Casado MÁ; Buti M
    J Viral Hepat; 2022 Mar; 29(3):227-230. PubMed ID: 34806812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viral Hepatitis and Human Immunodeficiency Virus Testing and Linkage to Care for Individuals Enrolled in an Opioid Treatment Program.
    Rowan SE; Kamis KF; Beum R; Bryan K; Gawenus L; Colon Sanchez D; Hurley H
    J Infect Dis; 2020 Sep; 222(Suppl 5):S384-S391. PubMed ID: 32877565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous Human Immunodeficiency Virus-Hepatitis B-Hepatitis C Point-of-Care Tests Improve Outcomes in Linkage-to-Care: Results of a Randomized Control Trial in Persons Without Healthcare Coverage.
    Bottero J; Boyd A; Gozlan J; Carrat F; Nau J; Pauti MD; Rougier H; Girard PM; Lacombe K
    Open Forum Infect Dis; 2015 Dec; 2(4):ofv162. PubMed ID: 26668814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in Central and Western Africa.
    Duchesne L; Hejblum G; Njouom R; Touré Kane C; Toni TD; Moh R; Sylla B; Rouveau N; Attia A; Lacombe K
    PLoS One; 2020; 15(8):e0238035. PubMed ID: 32833976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid HIV testing of clients of a mobile STD/HIV clinic.
    Liang TS; Erbelding E; Jacob CA; Wicker H; Christmyer C; Brunson S; Richardson D; Ellen JM
    AIDS Patient Care STDS; 2005 Apr; 19(4):253-7. PubMed ID: 15857197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for chronic hepatitis B and C virus infections in an urban sexually transmitted disease clinic: rationale for integrating services.
    Gunn RA; Murray PJ; Ackers ML; Hardison WG; Margolis HS
    Sex Transm Dis; 2001 Mar; 28(3):166-70. PubMed ID: 11289199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid point-of-care CD4 testing at mobile units and linkage to HIV care: an evaluation of community-based mobile HIV testing services in South Africa.
    Sloot R; Glenshaw MT; van Niekerk M; Meehan SA
    BMC Public Health; 2020 Apr; 20(1):528. PubMed ID: 32306930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective Evaluation of HIV Testing Technologies in a Clinical Setting: Protocol for Project DETECT.
    Stekler JD; Violette LR; Clark HA; McDougal SJ; Niemann LA; Katz DA; Chavez PR; Wesolowski LG; Ethridge SF; McMahan VM; Cornelius-Hudson A; Delaney KP
    JMIR Res Protoc; 2020 Jan; 9(1):e16332. PubMed ID: 32012115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-sectional survey of the extent and indicators of hepatitis C virus infection in Houston Department of Health and Human Services' sexually transmitted disease clinics.
    D'Souza G; Arafat R; Hwang L; Cunningham C; Shah S; Reynolds K
    J Viral Hepat; 2003 Mar; 10(2):134-40. PubMed ID: 12614470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of two rapid screening assays for detecting hepatitis C antibodies in resource-constrained settings.
    Kosack CS; Nick S
    Trop Med Int Health; 2016 May; 21(5):603-9. PubMed ID: 26945920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergency department targeted screening for hepatitis C does not improve linkage to care.
    Houri I; Horowitz N; Katchman H; Weksler Y; Miller O; Deutsch L; Shibolet O
    World J Gastroenterol; 2020 Aug; 26(32):4878-4888. PubMed ID: 32921964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program.
    Gunn RA; Lee MA; Callahan DB; Gonzales P; Murray PJ; Margolis HS
    Am J Prev Med; 2005 Jul; 29(1):27-33. PubMed ID: 15958248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barriers to the Treatment of Hepatitis C among Predominantly African American Patients Seeking Care in an Urban Teaching Hospital in Washington, D.C.
    Liu L; Daftary MN; Alzahrani MS; Ohanele C; Maneno MK
    J Natl Med Assoc; 2021 Apr; 113(2):147-157. PubMed ID: 32868101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.